$CTNM 4 SEC Filings

Filed On	Filing
08 Sep 2026	Form 4: Stengone Carmine N., Director Received 2,500 shares by exercise or conversion ($2.53K) · Sold 2,500 shares ($41.1K)
03 Aug 2026	Form 4: Stengone Carmine N., Director Received 2,500 shares by exercise or conversion ($2.53K) · Sold 2,500 shares ($40K)
10 Jul 2026	Form 4: Lorrain Daniel S., Chief Scientific Officer Received 1,015 shares by exercise or conversion ($1.03K) · Sold 1,015 shares ($16.2K) · Received 25 shares by exercise or conversion ($25.3) · 1 more
08 Jul 2026	Form 4: Stengone Carmine N., Director Received 2,500 shares by exercise or conversion ($2.53K) · Sold 2,500 shares ($40K)
02 Jul 2026	Form 4: Lorrain Daniel S., Chief Scientific Officer Received 28,826 shares by exercise or conversion ($29.1K) · Sold 28,826 shares ($462K) · Received 4,183 shares by exercise or conversion ($4.22K) · 1 more
01 Jul 2026	Form 4: Watkins Tim, CMO & Head of Development Received 10,833 shares by exercise or conversion ($48.7K) · Sold 10,833 shares ($174K)
01 Jul 2026	Form 4: Stengone Carmine N., Director Received 10,000 shares by exercise or conversion ($10.7K) · Sold 10,000 shares ($160K)
26 Jun 2026	Form 4: Miralles Gines Diego, Director Granted 19,000 Stock Option (right to buy)
26 Jun 2026	Form 4: Lyons-Williams Lori, Director Granted 19,000 Stock Option (right to buy)
26 Jun 2026	Form 4: Ware Olivia C, Director Granted 19,000 Stock Option (right to buy)
26 Jun 2026	Form 4: Schimmelpennink Evert B., Director Granted 19,000 Stock Option (right to buy)
26 Jun 2026	Form 4: Ignelzi Troy A., Director Granted 19,000 Stock Option (right to buy)
26 Jun 2026	Form 4: Brady Todd R., Director Granted 19,000 Stock Option (right to buy)
26 Jun 2026	Form 4: Boyce Sarah, Director Granted 19,000 Stock Option (right to buy)
01 Jun 2026	Form 4: Lorrain Daniel S., Chief Scientific Officer Sold 4,170 shares ($54.9K)
01 May 2026	Form 4: Lorrain Daniel S., Chief Scientific Officer Sold 4,170 shares ($54.7K)
06 Apr 2026	Form 4: Lorrain Daniel S., Chief Scientific Officer Sold 4,170 shares ($56K)
02 Mar 2026	Form 4: Lorrain Daniel S., Chief Scientific Officer Sold 4,170 shares ($62.6K)
02 Mar 2026	Form 4: Watkins Tim, CMO & Head of Development Received 3,611 shares by exercise or conversion ($16.2K) · Sold 3,611 shares ($54.2K)
26 Feb 2026	Form 4: Stengone Carmine N., Director Received 4,400 shares by exercise or conversion ($5.54K) · Sold 4,400 shares ($70.5K) · Received 2,700 shares by exercise or conversion ($3.4K) · 1 more

Comments